VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $34,899,000 | +9.1% | 243,863 | 0.0% | 9.08% | +11.2% |
| Q3 2014 | $31,995,000 | +13.8% | 243,863 | +9.4% | 8.17% | +13.9% |
| Q2 2014 | $28,111,000 | +97.6% | 222,890 | +106.6% | 7.17% | +94.6% |
| Q1 2014 | $14,223,000 | -16.0% | 107,890 | -25.2% | 3.68% | -6.5% |
| Q4 2013 | $16,940,000 | +7.3% | 144,295 | -4.6% | 3.94% | -3.6% |
| Q3 2013 | $15,785,000 | +21.2% | 151,295 | 0.0% | 4.09% | +15.0% |
| Q2 2013 | $13,023,000 | – | 151,295 | – | 3.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |